Visiting Indian External Affairs Minister S. Jaishankar made the pledge when President Gotabaya Rajapaksa asked him for vaccines produced in India, Rajapaksa's office said in a statement.
India’s drug regulator has approved two vaccines for emergency use for COVID-19 — one developed by Oxford University and U.K.-based drug maker AstraZeneca, and another by the Indian manufacturer Bharat Biotech.
Serum Institute of India, the world’s largest vaccine manufacturing company, has been contracted by AstraZeneca to make 1 billion doses for developing nations, including India. However, delivery of the vaccine outside India is likely to take a number of months.
COVID-19 cases have spiked in Sri Lanka in recent months. However, authorities have been undecided on a vaccine until last month.
Jaishankar is on a two-day visit to Sri Lanka.